Key result
Low-flow mediated constriction (L-FMC) is a novel technique based on the constrictor response to decreased flow, proposed to complement flow-mediated dilation in assessing endothelial function.
Answers are grounded in this paper and cite their sources.
Low-flow mediated constriction (L-FMC) is a novel technique that may complement flow-mediated dilation (FMD) in assessing endothelial function and predicting cardiovascular risk.
Given the prevalence of cardiovascular disease (CVD), early detection is crucial. Although traditional cardiovascular risk factors relate to future CVD, the predictive value of these risk factors can be relatively limited. Contemporary scientific attention has focused on alternative direct measures of arterial function. Based on the ability of the endothelium to acutely dilate in response to an increase in flow, 'flow mediated dilation' (FMD) was introduced approximately 20 years ago and is now an established non-invasive index of endothelial function predictive of future cardiovascular events. Recently, 'low-flow mediated constriction' (L-FMC) has been proposed as a complementary addition to FMD. The technique is based on the constrictor response to decreased flow and is claimed to improve the sensitivity and specificity of FMD. The aim of this review is to examine literature pertaining to this novel technique and to provide insight into the potential use of L-FMC in future research.
No takes yet. Share an insight, caveat, or question.
Humphreys et al. (2014) conducted a review in Cardiovascular disease. Low-flow mediated constriction (L-FMC) was evaluated. Low-flow mediated constriction (L-FMC) is a novel technique based on the constrictor response to decreased flow, proposed to complement flow-mediated dilation in assessing endothelial function.
Synapse has enriched 10 related papers. Consider them for comparative context: